01
LSTx
Lipid signalling therapeutics
New therapeutic opportunities derived from lipid mediators and their biological signalling activity.
Explore LSTx4Ammonium Biotech
Drug discovery technologies built for transfer
We develop proprietary drug discovery technologies and convert them into validated therapeutic assets for partners and new ventures.
What we do
From enabling technology to transferable assets
4Ammonium focuses on lipid chemistry, nucleic-acid delivery, small-molecule conjugation, formulation and drug repositioning.
Our platforms can generate proprietary compounds, new therapeutic applications and collaboration opportunities.
Technology platforms
Four routes to therapeutic value
Each platform addresses a different challenge in drug discovery.
02
NATx
Nucleic-acid therapeutics
Cationic lipid chemistry, oligonucleotide chemistry and conjugation strategies for nucleic-acid delivery.
Explore NATx03
SMDC
Small Molecule Drug Conjugates
Targeted transport and distribution strategies for tissue-specific delivery.
Explore SMDC04
Drug Rescue
Renewed therapeutic potential
Repositioning, reformulation and combination strategies for new therapeutic solutions.
Explore Drug Rescue01 · Technology
Build
Develop proprietary chemistry, delivery strategies and enabling technologies.
02 · Results / Assets
Validate
Apply the technology to generate new assets.
03 · Transfer
Partner
Advance selected assets through licensing, collaboration or dedicated ventures.
Partnering
Let’s explore what we can develop together
Tell us about a molecule, delivery challenge, therapeutic hypothesis or development opportunity that could benefit from our technologies.
Start a conversation